Related Experiment Video
Updated: Nov 10, 2025

Measuring Cardiac Autonomic Nervous System ANS Activity in Children
Published on: April 29, 2013
Mid-term outcome of children with latent rheumatic heart disease in eastern Nepal
Nikesh Raj Shrestha1, Dorothea Bruelisauer2, Surendra Uranw3
1Department of Cardiology, Neuro Cardio and Multispeciality Hospital, Biratnagar, Nepal.
Insights
Early echocardiographic screening detects subclinical rheumatic heart disease in children. Definite rheumatic heart disease regressed in 27.8% of cases, while borderline cases showed spontaneous reversibility in less than half.
Area of Science:
- Pediatric Cardiology
- Rheumatic Heart Disease Epidemiology
- Echocardiography
Background:
- Rheumatic heart disease (RHD) is a significant global health concern, particularly in endemic regions.
- Early detection of subclinical RHD through echocardiography is crucial for timely intervention.
- The natural history of latent RHD in children requires further elucidation.
Purpose of the Study:
- To prospectively investigate the course of subclinical rheumatic heart disease detected by echocardiography in children.
- To assess disease regression, progression, and stability in definite and borderline RHD cases.
- To identify potential predictors of disease course and adherence to secondary antibiotic prophylaxis.
Main Methods:
- Prospective cohort study involving children with echocardiographic evidence of definite or borderline RHD based on World Heart Federation Criteria.
- Follow-up assessments were conducted to evaluate valvular lesions and clinical status.
- Statistical analysis, including univariate analysis, was performed to identify predictors.
Main Results:
- Of 53 children with definite (36) or borderline (17) RHD, 44 were followed for a median of 1.9 years.
- Definite RHD regressed in 27.8% of cases; 55.6% had stable disease.
- Borderline RHD showed regression in 41.2%, progression in 17.6%, and stability in 23.5%.
Conclusions:
- Definite rheumatic heart disease regressed in approximately one in four children.
- Borderline RHD demonstrated spontaneous reversibility in less than half of cases, with progression to definite RHD in one in five.
- No predictors for disease regression or adherence issues were identified.
Introduction:
Systematic echocardiographic screening of children in regions with an endemic pattern of rheumatic heart disease allows for the early detection of valvular lesions suggestive of subclinical rheumatic heart disease. The natural course of latent rheumatic heart disease is, however, incompletely understood at this time.
Methods:
We performed a prospective cohort study of children detected to have echocardiographic evidence of definite or borderline rheumatic heart disease according to the World Heart Federation Criteria.
Results:
Among 53 children found to have definite (36) or borderline (17) rheumatic heart disease, 44 (83%) children underwent follow-up at a median of 1.9 years (IQR 1.1-4.5). The median age of the children was 11 years (IQR 9-14) and 34 (64.2%) were girls. Among children with definite rheumatic heart disease, 21 (58.3%) were adherent to secondary antibiotic prophylaxis, 7 (19.4%) were not, information on adherence was missing in 2 (5.6%) children and 6 (16.7%) were lost to follow-up. Regression of disease was observed in 10 children (27.8%), whereas 20 children (55.6%) had stable disease. Among children adherent to secondary prophylaxis, seven (33.3%) showed regression of disease. Among children with borderline disease, seven (41.2%) showed regression of disease, three (17.6%) progression of disease, four (23.5%) remained stable and three (17.6%) were lost to follow-up. On univariate analysis, we identified no predictors of disease regression, and no predictors for lost to follow-up or non-adherence with secondary antibiotic prophylaxis.
Conclusion:
Definite rheumatic heart disease showed regression in one in four children. Borderline disease was spontaneously reversible in less than half of the children and progressed to definite rheumatic heart disease in one in five children.
Trial Registration Number:
NCT01550068.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests

